Skeletal Muscle Oxygenation in Critically Ill

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2008 by University Medical Centre Ljubljana.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
University Medical Centre Ljubljana
ClinicalTrials.gov Identifier:
NCT00384644
First received: October 4, 2006
Last updated: June 4, 2008
Last verified: June 2008
  Purpose

It is possible to measure skeletal muscle tissue oxygenation (StO2) using near infrared spectroscopy(NIRS). It is performed non invasively. We want to compare usually used invasive methods for assessing adequacy of flow to StO2 in critically ill. Aim is to faster and non invasively estimate adequacy of flow to make therapeutic algorithms efficient.


Condition Intervention
Heart Failure
Sepsis
Septic Shock
Cardiogenic Shock
Device: NiRS measurment of tissue oxygenation

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Skeletal Muscle Oxygenation in Critically Ill

Resource links provided by NLM:


Further study details as provided by University Medical Centre Ljubljana:

Estimated Enrollment: 200
Study Start Date: April 2004
Estimated Study Completion Date: December 2010
Estimated Primary Completion Date: January 2009 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
1
sepsis, septic shock ptients
Device: NiRS measurment of tissue oxygenation
NiRS measurment of tissue oxygenation
2
cardiogenic shock patients
Device: NiRS measurment of tissue oxygenation
NiRS measurment of tissue oxygenation

  Show Detailed Description

  Eligibility

Ages Eligible for Study:   18 Years to 95 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Intensive care patients

Criteria

Inclusion Criteria:

  • all typs of shock (cardiogenic, septic, hypovolemic, obstractive)

Exclusion Criteria:

  • patients/relatives refuse to participate in study
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00384644

Contacts
Contact: Matej Podbregar, MD PhD +386 40 215960 matej.podbegar@guest.arnes.si
Contact: Hugon Mozina, MD +386 41 779078 hugo.mozina@kclj.si

Locations
Slovenia
Clinical Center Ljubljana Recruiting
Ljubljana, Slovenia, 1000
Contact: Matej Podbregar, MD PhD    +386 40 215960    matej.podbregar@guest.arnes.si   
Sub-Investigator: Hugon Mozina, MD         
Sponsors and Collaborators
University Medical Centre Ljubljana
Investigators
Principal Investigator: Matej Podbregar, MD PhD Medical Faculty, University of Ljubljana
  More Information

Publications:
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Matej Podbregar, UMC Ljubljana
ClinicalTrials.gov Identifier: NCT00384644     History of Changes
Other Study ID Numbers: NIRS-1
Study First Received: October 4, 2006
Last Updated: June 4, 2008
Health Authority: Slovenia: Ministry of Health

Keywords provided by University Medical Centre Ljubljana:
heart failure
sepsis
septic shock
cardiogenic shock

Additional relevant MeSH terms:
Critical Illness
Heart Failure
Sepsis
Shock
Shock, Cardiogenic
Shock, Septic
Disease Attributes
Pathologic Processes
Heart Diseases
Cardiovascular Diseases
Infection
Systemic Inflammatory Response Syndrome
Inflammation
Myocardial Infarction
Myocardial Ischemia
Vascular Diseases

ClinicalTrials.gov processed this record on April 16, 2014